This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Sterling Winthrop Inc.. Active years: 1994-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1995
Title: Joseph W. Guiles: Innovator in Antitumor Agents
Introduction
Joseph W. Guiles is a notable inventor based in Chester Springs, PA (US). He has made significant contributions to the field of antitumor agents, holding a total of 2 patents. His work focuses on innovative compounds that have the potential to treat tumors and cancer in mammals.
Latest Patents
Guiles' latest patents include the development of thioxanthenone antitumor agents. Specifically, he has disclosed 1-[[(Dialkylamino)alkyl]amino]-4-substituted-thioxanthen-9-ones as effective antitumor agents. These compositions, along with methods for treating tumors and cancer in mammals, represent a significant advancement in cancer treatment.
Career Highlights
Joseph W. Guiles is associated with Sterling Winthrop Inc., where he has been able to apply his expertise in the development of pharmaceutical innovations. His work has contributed to the advancement of medical treatments, particularly in oncology.
Collaborations
Throughout his career, Guiles has collaborated with notable colleagues, including Theodore C. Miller and Joseph C. Collins. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Joseph W. Guiles stands out as an influential inventor in the realm of antitumor agents, with a focus on developing effective treatments for cancer. His contributions continue to impact the field of medicine positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile